Evidence map›Paper›PMID 30899177›Full record

ArticleSaudi journal of biological sciences2019

Comparative study on different therapies on patients with primary central nervous system lymphoma.

Xuchu Yang, Xinfeng Zhang, Huaizhang Wang, Shuochuan Liu, Wenwen Jin, Yingyue Li, Huaimin Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuchu YangAffiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.
Xinfeng ZhangAffiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.
Huaizhang WangAffiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.
Shuochuan LiuNanchang University Queen Mary School, Nanchang 330000, China.
Wenwen JinMedical Engineering Technology and Data Mining Institute of Zhengzhou University, Zhengzhou 450000, China.
Yingyue LiMedical Engineering Technology and Data Mining Institute of Zhengzhou University, Zhengzhou 450000, China.
Huaimin LiuAffiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo compare and analyze three therapies on patients with primary central nervous system lymphoma (PCNSL), aiming to provide evidences for future treatment and prognosis.

methodsClinical data of 26 cases of PCNSL with normal immune system confirmed by postoperative pathology were retrospectively analyzed. Among them there were six cases with operation only, nine cases with operation and radiotherapy, and 11 cases with operation, radiotherapy and chemotherapy, and their survival rate was compared as well.

resultsThe survival time of patients with operation only, operation combined with radiotherapy and operation combined with radiotherapy and chemotherapy was 6-11 months, 15-24 months and 24-51 months, respectively. And their median survival time was only nine months, 21 months and 38 months, respectively.

conclusionsOperation combined with radiotherapy and chemotherapy can dramatically extend PCNSL patients' survival time, therefore, it can be regarded as the first-line therapy.

Indexed as

ChemotherapyPrimary central nervous system lymphomaRadiotherapySurgical therapy

Identifiers

PMID30899177
PMCPMC6408717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.